Should ChemoCentryx Be in Your Portfolio?

This post was originally published on this site

https://i-invdn-com.akamaized.net/news/LYNXNPEB6R0AQ_M.jpg

CCXI’s overarching goal is to provide the masses with therapeutics that combat different types of cancer, autoimmune diseases, and inflammatory disorders. This is certainly a desirable aim, yet reaching it is not exactly easy. As medical industry insiders admit, it might take decades or even centuries to develop a cure for cancer.

Does CCXI belong in your portfolio? Let’s take a look at the details of this biopharmaceutical stock to answer that question.

Continue reading on StockNews